ICUI - ICU Medical, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5 3.44B
Enterprise Value 3 3.15B
Trailing P/E 77.11
Forward P/E 1 20.37
PEG Ratio (5 yr expected) 1 1.33
Price/Sales (ttm) 2.62
Price/Book (mrq) 2.61
Enterprise Value/Revenue 3 2.40
Enterprise Value/EBITDA 6 13.56

Trading Information

Stock Price History

Beta (3Y Monthly) 0.85
52-Week Change 3 -45.11%
S&P500 52-Week Change 3 0.90%
52 Week High 3 312.45
52 Week Low 3 160.00
50-Day Moving Average 3 233.16
200-Day Moving Average 3 235.34

Share Statistics

Avg Vol (3 month) 3 201.24k
Avg Vol (10 day) 3 323.85k
Shares Outstanding 5 20.61M
Float 19.19M
% Held by Insiders 1 7.13%
% Held by Institutions 1 93.55%
Shares Short (Jul 31, 2019) 4 801.7k
Short Ratio (Jul 31, 2019) 4 7.51
Short % of Float (Jul 31, 2019) 4 5.85%
Short % of Shares Outstanding (Jul 31, 2019) 4 3.88%
Shares Short (prior month Jun 28, 2019) 4 843.59k

Dividends & Splits

Forward Annual Dividend Rate 4 N/A
Forward Annual Dividend Yield 4 N/A
Trailing Annual Dividend Rate 3 N/A
Trailing Annual Dividend Yield 3 N/A
5 Year Average Dividend Yield 4 N/A
Payout Ratio 4 0.00%
Dividend Date 3 N/A
Ex-Dividend Date 4 N/A
Last Split Factor (new per old) 2 2/3
Last Split Date 3 Mar 18, 2002

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq) Jun 30, 2019

Profitability

Profit Margin 3.56%
Operating Margin (ttm) 11.89%

Management Effectiveness

Return on Assets (ttm) 6.19%
Return on Equity (ttm) 3.63%

Income Statement

Revenue (ttm) 1.31B
Revenue Per Share (ttm) 63.85
Quarterly Revenue Growth (yoy) -13.40%
Gross Profit (ttm) 570.03M
EBITDA 232.56M
Net Income Avi to Common (ttm) 46.7M
Diluted EPS (ttm) 2.16
Quarterly Earnings Growth (yoy) -26.50%

Balance Sheet

Total Cash (mrq) 314.88M
Total Cash Per Share (mrq) 15.24
Total Debt (mrq) 37.48M
Total Debt/Equity (mrq) 2.84
Current Ratio (mrq) 3.58
Book Value Per Share (mrq) 63.78

Cash Flow Statement

Operating Cash Flow (ttm) 103.52M
Levered Free Cash Flow (ttm) 108.18M